Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MC+ is a dietary supplement product, primarily marketed by Bio-Tech Pharmacal, that combines magnesium (typically in the form of magnesium citrate) with Vitamin C (ascorbic acid). Magnesium is an essential mineral that serves as a cofactor for over 300 enzymatic reactions in the human body, including those involved in protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Vitamin C is a potent antioxidant and essential nutrient involved in collagen synthesis, immune function, and the absorption of non-heme iron. While the name "MC+" is also used in medical contexts to refer to specific spinal implants (e.g., the MC+ Partial Vertebral Body Replacement by LDR Spine) or as a clinical abbreviation for "mutation carriers" in genetic studies, the most common reference to a consumable substance with this exact name is the magnesium and Vitamin C formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MC+.